Back to Journals » Neuropsychiatric Disease and Treatment » Volume 14

Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials

Total article views   Abstract views HTML views PDF downloads Totals
7,295 Dovepress* 5,999 850+ 1,283 6,849
PubMed Central* 0 446 241 446
Totals 5,999 1,296 1,524 7,295
*Since 1 October 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
13 1 0 0 5 7

View citations on PubMed Central and Google Scholar